Results 231 to 240 of about 28,602,314 (397)

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Optimizing Sensor Data Interpretation via Hybrid Parametric Bootstrapping. [PDF]

Sensors (Basel)
Golovko VV.
europepmc   +1 more source

Interobserver and intermethod variability in data interpretation of breast strain elastography in suspicious breast lesions [PDF]

Turk J Med Sci, 2021
Turnaoğlu H, Haberal KM, Arslan S, Yavuz Çolak M, Ulu Öztürk F, Uslu N.   +5 more
europepmc   +1 more source

The interpretation of recent 21-cm line data in terms of large-scale galactic structure [PDF]

, 1964
G. Westerhout
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

MWENA: a novel sample re-weighting-based algorithm for disease classification and data interpretation using extracellular vesicles omics data. [PDF]

BMC Genomics
Liao S, Long H, Zhu Q, Li S, Li L, Lu S, Tang N, Liang Y, Dong M.   +8 more
europepmc   +1 more source

DXA-Derived Adiposity and Lean Indices for Management of Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and Reporting Tips. [PDF]

Front Rehabil Sci, 2021
Minetto MA, Busso C, Lalli P, Gamerro G, Massazza G.   +4 more
europepmc   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Deciphering Design of Aggregation-Induced Emission Materials by Data Interpretation. [PDF]

Adv Sci (Weinh)
Gong J, Deng Z, Xie H, Qiu Z, Zhao Z, Tang BZ.   +5 more
europepmc   +1 more source

A count-based decision method for target blood pressure achievement in home blood pressure monitoring data interpretation for clinical practices. [PDF]

Sci Rep, 2022
Shin J, Lee Y, Ihm SH, Shin JH, Kim HJ, Kim BS, Park HC, Lim YH, Park JK, Heo R, Kim WH.   +10 more
europepmc   +1 more source